4JT9 | Crystal Structure of human SIRT3 with ELT inhibitor 3 [14-(4-{2-[(methylsulfonyl)amino]ethyl}piperidin-1-yl)thieno[3,2-d]pyrimidine-6-carboxamide] | date | 2013-03-22 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Dai, H. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.24 | ||||||||||||
ligand | 1NS, GOL, NA, ZN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Discovery of Thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2 and SIRT3., Disch JS, Evindar G, Chui CH, Blum CA, Dai H, Jin L, Schuman E, Lind KE, Belyanskaya SL, Deng J, Coppo FT, Aquilani L, Graybill TL, Cuozzo JW, Lavu S, Mao C, Vlasuk GP, Perni RB, J Med Chem. 2013 Apr 9. PMID:23570514 |
Data retrieval |
View 4JT9 in 3D |
Visual 3D analysis of 4JT9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4JT9 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |